← Leaderboards
David Alan Kass
Johns Hopkins University
$45,555,857
Attributed
$53,699,487
Total exposure
20
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$76,523,600 · 21
By mechanism
P01$29,036,703 · 7
T32$20,015,055 · 1
R01$10,555,062 · 6
R35$9,305,708 · 2
P50$3,633,430 · 3
UH3$2,376,851 · 1
Top collaborators
- Wendy S Post10 shared
- Paul M Hassoun5 shared
- Deok-Ho Kim5 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Eiki Takimoto$2,336,229
- Brian Leei Lin$758,660
Others in their field
Top investigators on “Cardiac”
- Judith S Hochman · New York University School Of Medicine$110,228,771
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$69,868,084
- Rose A Gubitosi-Klug · Case Western Reserve University$61,225,818
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,141,827
- Joseph C Wu · Stanford University$53,027,789
- Pamela Susan Douglas · Duke University$51,506,531
Research focus
CardiacStressHeart FailureSignal TransductionBaseMolecularHeartMuscle CellsCardiac MyocytesProteinsFunctional DisorderPathway InteractionsProteomicsResponseCardiomyopathiesLinkMouse ModelPhysiologicalProgramsPressureBlood VesselsRegulationCalciumAdrenergic Agents
Grant awards (114)
Intersection of Obesity and Heart Failure with Preserved Ejection Fraction$1,124,864
R35 · FY2025 · HL · contact PI
Pathophysiology of Myocardial Disease$517,852
T32 · FY2025 · HL
Pathophysiology of Myocardial Disease$1,120,228
T32 · FY2024 · HL
Intersection of Obesity and Heart Failure with Preserved Ejection Fraction$1,108,586
R35 · FY2024 · HL · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$776,816
UH3 · FY2024 · TR
Pathophysiology of Myocardial Disease$1,083,084
T32 · FY2023 · HL
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$789,923
UH3 · FY2023 · TR
Intersection of Obesity and Heart Failure with Preserved Ejection Fraction$736,477
R35 · FY2023 · HL · contact PI
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$432,855
R35 · FY2023 · HL · contact PI
Pathophysiology of Myocardial Disease$1,056,023
T32 · FY2022 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$981,748
R35 · FY2022 · HL · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$810,112
UH3 · FY2022 · TR
Pathophysiology of Myocardial Disease$1,009,162
T32 · FY2021 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$981,748
R35 · FY2021 · HL · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$807,541
UG3 · FY2021 · TR
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$981,748
R35 · FY2020 · HL · contact PI
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy$793,250
UG3 · FY2020 · TR
Pathophysiology of Myocardial Disease$676,148
T32 · FY2020 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$981,748
R35 · FY2019 · HL · contact PI
Pathophysiology of Myocardial Disease$930,892
T32 · FY2019 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$981,073
R35 · FY2018 · HL · contact PI
Pathophysiology of Myocardial Disease$897,559
T32 · FY2018 · HL
Leveraging Protein Kinase G-1 Nanodomain Control and Molecular Targeting to Enhance its Therapeutic Use Against Myocardial Disease$994,861
R35 · FY2017 · HL · contact PI
Pathophysiology of Myocardial Disease$870,731
T32 · FY2017 · HL
Myocyte Isolation and Myocyte and Cardiac Physiology$137,269
P01 · FY2017 · HL · contact PI
Pathophysiology of Myocardial Disease$854,026
T32 · FY2016 · HL
Mechanisms of Right Ventricular Dysfunction in PAH$633,919
R01 · FY2016 · HL
TRPC6 Hyperactivity and Cardiac Dystrophinopathy$407,604
R01 · FY2016 · HL · contact PI
PKG Redox Modulation of Cardiac Function and Disease$405,000
R01 · FY2016 · HL · contact PI
Myocyte Isolation and Myocyte and Cardiac Physiology$148,750
P01 · FY2016 · HL · contact PI
Pathophysiology of Myocardial Disease$723,208
T32 · FY2015 · HL · contact PI
Mechanisms of Right Ventricular Dysfunction in PAH$641,968
R01 · FY2015 · HL
PKG Redox Modulation of Cardiac Function and Disease$398,925
R01 · FY2015 · HL · contact PI
Myocyte Isolation and Myocyte and Cardiac Physiology$130,015
P01 · FY2015 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,256,884
P01 · FY2014 · HL · contact PI
Pathophysiology of Myocardial Disease$733,956
T32 · FY2014 · HL · contact PI
Mechanisms of Right Ventricular Dysfunction in PAH$658,659
R01 · FY2014 · HL
Modulation of p-adrenergic and myofilament responses by Cardiac Resynchronization$477,860
P01 · FY2014 · HL · contact PI
PKG Redox Modulation of Cardiac Function and Disease$396,900
R01 · FY2014 · HL · contact PI
Myocyte Isolation and Myocyte and Cardiac Physiology$145,310
P01 · FY2014 · HL · contact PI
Administrative Core$118,495
P01 · FY2014 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,192,403
P01 · FY2013 · HL · contact PI
Pathophysiology of Myocardial Disease$791,940
T32 · FY2013 · HL · contact PI
Mechanisms of Right Ventricular Dysfunction in PAH$655,665
R01 · FY2013 · HL
Modulation of p-adrenergic and myofilament responses by Cardiac Resynchronization$464,206
P01 · FY2013 · HL · contact PI
PKG Redox Modulation of Cardiac Function and Disease$385,560
R01 · FY2013 · HL · contact PI
Myocyte Isolation and Myocyte and Cardiac Physiology$132,167
P01 · FY2013 · HL · contact PI
Administrative Core$115,110
P01 · FY2013 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,302,943
P01 · FY2012 · HL · contact PI
Pathophysiology of Myocardial Disease$791,473
T32 · FY2012 · HL · contact PI
Mechanisms of Right Ventricular Dysfunction in PAH$703,702
R01 · FY2012 · HL
Modulation of p-adrenergic and myofilament responses by Cardiac Resynchronization$487,610
P01 · FY2012 · HL · contact PI
Myocyte Isolation and Myocyte and Cardiac Physiology$155,125
P01 · FY2012 · HL · contact PI
Administrative Core$120,914
P01 · FY2012 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,302,943
P01 · FY2011 · HL · contact PI
Pathophysiology of Myocardial Disease$730,491
T32 · FY2011 · HL · contact PI
Modulation of p-adrenergic and myofilament responses by Cardiac Resynchronization$493,883
P01 · FY2011 · HL · contact PI
Regulation of Cardiac Stress Responses by PDE5a$469,649
R01 · FY2011 · HL · contact PI
RIGHT VENTRICULO-PULMONARY VASCULAR COUPLING IN PAH$381,992
P50 · FY2011 · HL · contact PI
Myocyte Isolation and Myocyte and Cardiac Physiology$164,000
P01 · FY2011 · HL · contact PI
Administrative Core$116,040
P01 · FY2011 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,318,943
P01 · FY2010 · HL · contact PI
Pathophysiology of Myocardial Disease$528,764
T32 · FY2010 · HL · contact PI
Modulation of p-adrenergic and myofilament responses by Cardiac Resynchronization$498,413
P01 · FY2010 · HL · contact PI
Regulation of Cardiac Stress Responses by PDE5a$467,098
R01 · FY2010 · HL · contact PI
RIGHT VENTRICULO-PULMONARY VASCULAR COUPLING IN PAH$374,479
P50 · FY2010 · HL · contact PI
Administrative Core$119,667
P01 · FY2010 · HL · contact PI
Regulation of Cardiac Stress Responses by PDE5a$13,653
R01 · FY2010 · HL · contact PI
Pathophysiology of Myocardial Disease$709,059
T32 · FY2009 · HL · contact PI
Regulation of Cardiac Stress Responses by PDE5a$409,450
R01 · FY2009 · HL · contact PI
RIGHT VENTRICULO-PULMONARY VASCULAR COUPLING IN PAH$373,858
P50 · FY2009 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,303,149
P01 · FY2008 · HL · contact PI
Pathophysiology of Myocardial Disease$703,357
T32 · FY2008 · HL · contact PI
RIGHT VENTRICULO-PULMONARY VASCULAR COUPLING IN PAH$410,523
P50 · FY2008 · HL · contact PI
Regulation of Cardiac Stress Responses by PDE5a$409,450
R01 · FY2008 · HL · contact PI
CORE--ANIMAL CORE$372,540
P01 · FY2008 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,290,606
P01 · FY2007 · HL · contact PI
Pathophysiology of Myocardial Disease$794,521
T32 · FY2007 · HL · contact PI
RIGHT VENTRICULO-PULMONARY VASCULAR COUPLING IN PAH$414,714
P50 · FY2007 · HL · contact PI
CORE--ANIMAL CORE$369,614
P01 · FY2007 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony & Resynchronization$2,299,468
P01 · FY2006 · HL · contact PI
Pathophysiology of Myocardial Disease$748,883
T32 · FY2006 · HL · contact PI
CORE--ANIMAL CORE$215,017
P01 · FY2006 · HL · contact PI
Pathobiology of Cardiac Dyssynchrony &Resynchronization$2,295,607
P01 · FY2005 · HL
Pathophysiology of Myocardial Disease$736,161
T32 · FY2005 · HL
Cardiovascular Stiffening in Aged Patients with CHF$442,836
R01 · FY2005 · AG
Role of Stretch to Endothelial Pulse-Perfusion Response$367,875
R01 · FY2005 · HL
CORE--ANIMAL CORE$209,092
P01 · FY2005 · HL
Pathobiology of Cardiac Dyssynchrony &Resynchronization$2,261,167
P01 · FY2004 · HL
Pathophysiology of Myocardial Disease$440,636
T32 · FY2004 · HL
Cardiovascular Stiffening in Aged Patients with CHF$431,111
R01 · FY2004 · AG
Role of Stretch to Endothelial Pulse-Perfusion Response$367,875
R01 · FY2004 · HL
CORE--ANIMAL CORE$203,090
P01 · FY2004 · HL
CORE A--ADMINISTRATIVE CORE$98,821
P01 · FY2004 · HL
Pathophysiology of Myocardial Disease$745,173
T32 · FY2003 · HL
Cardiovascular Stiffening in Aged Patients with CHF$414,874
R01 · FY2003 · AG
Role of Stretch to Endothelial Pulse-Perfusion Response$367,875
R01 · FY2003 · HL
Pathophysiology of Myocardial Disease$663,508
T32 · FY2002 · HL
Cardiovascular Stiffening in Aged Patients with CHF$439,684
R01 · FY2002 · AG
Role of Stretch to Endothelial Pulse-Perfusion Response$367,875
R01 · FY2002 · HL
CORE--MOUSE PRODUCTION AND IN VIVO VENTRICULAR FUNCTION$233,291
P01 · FY2002 · HL
Core--animal model and cell$209,733
P50 · FY2002 · HL
Core--animal model and cell$209,733
P50 · FY2002 · HL
Mechanism of neurohumoral modulation of cardiac remodeling$209,733
P50 · FY2002 · HL
Mechanism of neurohumoral modulation of cardiac remodeling$209,733
P50 · FY2002 · HL
Pathophysiology of Myocardial Disease$658,948
T32 · FY2001 · HL
CORE--MOUSE PRODUCTION AND IN VIVO VENTRICULAR FUNCTION$233,291
P01 · FY2001 · HL
Core--animal model and cell$209,733
P50 · FY2001 · HL
Mechanism of neurohumoral modulation of cardiac remodeling$209,733
P50 · FY2001 · HL
PATHOPHYSIOLOGY OF MYOCARDIAL DISEASE$499,272
T32 · FY2000 · HL
PATHOPHYSIOLOGY OF VENTRICULAR-VASCULAR INTERACTION$297,855
R01 · FY2000 · HL
CORE--MOUSE PRODUCTION AND IN VIVO VENTRICULAR FUNCTION$253,000
P01 · FY2000 · HL
Core--animal model and cell$209,733
P50 · FY2000 · HL
Mechanism of neurohumoral modulation of cardiac remodeling$209,733
P50 · FY2000 · HL